As part of its Vaccine Day this week, the company has updated its vaccine developement timeline and unveiled results from early stage mRNA vaccine trials. Moderna expects to begin three phase 1 clinical trials for two HIV vaccine candidates, mRNA-1644 and mRNA-1574, in 2021.
https://www.biopharma-reporter.com/Article/2021/04/15/Moderna-to-take-mRNA-flu-and-HIV-vaccines-into-Phase-1-trials-this-year
https://www.biopharma-reporter.com/Article/2021/04/15/Moderna-to-take-mRNA-flu-and-HIV-vaccines-into-Phase-1-trials-this-year